BioLife Solutions stock is in a Symmetrical Triangle pattern as the company makes big moves in the biotechnology shipping container space.
Motif Bio stock is a high risk, high reward gambit on iclaprim, an antibiotic drug that can kill antibiotic resistant bacteria.
Reata Pharmaceuticals stock has heavy insider buying after positive phase 2 trial results on its drug bardoxolone.
Illumina stock has a positive divergence between large players volume and price while the company's sales to China are exploding higher.
Medidata Solutions stock has a beautiful rising large players volume plot while the stock does a double bottom test. The speed up of FDA approvals in order to lower drug prices should benefit this company.
Aeterna Zentaris stock is a short-term play on the PDUFA date of December 30, 2017. The gambit is that the company will get FDA approval of Macrilen.
Allergan stock is a turnaround gambit on the stock being crushed over fears of a Botox competitor. Large players volume is rising and the Twiggs Money Flow just went positive.
pSivida stock has a good looking Symmetrical Triangle consolidation pattern. The Twiggs Money Flow has been rising into the consolidation pattern which could suggest a breakout is coming.
Sarepta Therapeutics could get European marketing approval for Exondys 51 at any time which will boost sales. Meanwhile, the company has great growth and is advancing other drugs through its pipeline.
Adamis Pharmaceuticals is looking at various licensing partners for its FDA approved Symjepi which will compete against Mylan's EpiPen. As soon as the company announces a licensing partner, this stock could explode over 130 percent higher.